Top Section/Ad
Top Section/Ad
Most recent
M&A could be much needed shot in the arm but dollars expected to dominate
Deal includes $1bn 3.75 year term loan
The German pharmaceutical wholesaler was upgraded to BBB- by S&P last month
US drug company Eli Lilly jolted the dollar market awake on Wednesday with an eight-part jumbo trade to fund two recent acquisitions
More articles/Ad
More articles/Ad
More articles
-
More companies are getting ratings to woo bond investors -
Europe's biggest IPO of the year so far gains traction with investors
-
After the listings in February delivered, Galderma adds fuel to the European IPO recovery
-
Long delayed listing of Nestlé's former skincare division is finally underway
-
LivaNova and MicroStrategy ride US tech convertible wave as maturity wall pushes issuers to refinance
-
Bankers hopeful more supply will follow, but no pipeline forthcoming
